まとめ
長期効力を有するベンゾジアゼピンから短期効力を有するベンゾジアゼピンに切り替えると,離脱症状が長引く可能性があります. これは, benzodiazepineの投与量を毎日変更する際の潜在的なリスクを強調しています.
科学分野:
- 薬理学 薬理学とは
- クリニカル・メディシン 臨床医学
- 精神科医は精神病を患っている.
背景:
- ベンゾジアゼピンを長期にわたって毎日服用することは,様々な症状に共通しています.
- ベンゾジアゼピンは,半減期に基づいて短効または長効に分類されます.
- 治療管理中に,異なるベンゾジアゼピンタイプの間の置換が発生することがあります.
研究 の 目的:
- ベンゾジアゼピンの種類を変えた後に離脱症候群の発生を報告する.
- 長期効力を有するベンゾジアゼピンと短期効力を有するベンゾジアゼピンを代用する臨床的影響を調査する.
- 短期効果ベンゾジアゼピンと長期効果ベンゾジアゼピンの使用の比較的な側面について議論する.
主な方法:
- 離脱症状を経験した2人の患者のケーススタディ.
- ベンゾジアゼピンの使用期間および種類を含む詳細な薬物使用歴.
- 離脱症状とその持続時間に関する観察と記録.
主要な成果:
- 2人の患者は,長効ベンゾジアゼピンから短効ベンゾジアゼピンに切り替えると,離脱症候群を発症した.
- 離脱症状は,両方のケースで少なくとも1ヶ月間続いた.
- 代用薬は,オクサゼパムをディアゼパムに,テマゼパムをフルラゼパム塩化水素に,それぞれ1日1回投与で代用した.
結論:
- 短効ベンゾジアゼピンと長効ベンゾジアゼピンを代用すると,たとえ1日1回投与であっても,著しい離脱を促す可能性があります.
- 長期にわたってベンゾジアゼピンを使用した歴のある患者は特に脆弱です.
- ベンゾジアゼピン治療の変更を管理する際には,薬理学的な違いを慎重に考慮することが重要です.
さらに関連する動画
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
02:32An Intraperitoneal Injection Technique in Adult Zebrafish that Minimizes Body Damage and Associated Mortality
Published on: March 29, 2024
関連する概念動画
Antihypertensive Drugs: Thiazide-Class Diuretics
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
